EFTR (eFFECTOR Therapeutics) FCF Margin %: 0.00% (As of Mar. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is eFFECTOR Therapeutics FCF Margin %?

eFFECTOR Therapeutics EFTR FCF Margin % is 0.00% as of Mar. 2024.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. eFFECTOR Therapeutics's Free Cash Flow for the three months ended in Mar. 2024 was $-7.28 Mil. eFFECTOR Therapeutics's Revenue for the three months ended in Mar. 2024 was $0.00 Mil. Therefore, eFFECTOR Therapeutics's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, eFFECTOR Therapeutics's current FCF Yield % is -2,927,500.00%.

The historical rank and industry rank for eFFECTOR Therapeutics's FCF Margin % or its related term are showing as below:


EFTR's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -82.715
* Ranked among companies with meaningful FCF Margin % only.

eFFECTOR Therapeutics FCF Margin % Related Terms

eFFECTOR Therapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for eFFECTOR Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

eFFECTOR Therapeutics FCF Margin % Chart

eFFECTOR Therapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
FCF Margin %
32.57 0.00 0.00 0.00

eFFECTOR Therapeutics Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

EFTR vs NTBLQ, MTEM, VRTX: FCF Margin % Comparison

For the Biotechnology subindustry, eFFECTOR Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

eFFECTOR Therapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, eFFECTOR Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where eFFECTOR Therapeutics's FCF Margin % falls into.


eFFECTOR Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

eFFECTOR Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-29.647/0
= %

eFFECTOR Therapeutics's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-7.278/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
eFFECTOR Therapeutics (EFTR) has a FCF Margin % of 0.00% as of Mar. 2024. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on eFFECTOR Therapeutics and its competitors.
Is eFFECTOR Therapeutics' FCF Margin % too high?
eFFECTOR Therapeutics' current FCF Margin % is 0.00%.
How does eFFECTOR Therapeutics' FCF Margin % compare to NTBLQ and MTEM?
eFFECTOR Therapeutics' FCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on eFFECTOR Therapeutics and its competitors. eFFECTOR Therapeutics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is eFFECTOR Therapeutics stock overvalued right now?
eFFECTOR Therapeutics (EFTR) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For eFFECTOR Therapeutics (EFTR), the current FCF Margin % is 0.00% as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

eFFECTOR Therapeutics Business Description

Address 142 North Cedros Avenue, Suite B, Solana Beach, CA, USA, 92075
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).